ReviewFrontiers in pharmacology2025

Diabetic cardiomyopathy and COVID-19: intersecting pathways and amplified cardiovascular risk.

Swati Prakash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.